RFL
Rafael Holdings, Inc.
A healthcare holding company in Newark, New Jersey, Rafael Holdings backs early-stage drug and medical-device ventures, with its lead therapy Trappsol® Cyclo™ in late-stage trials for the rare Niemann-Pick type C1 disease and the FDA-cleared VECTR System for ligament-release surgery. It was spun off in 2018 from IDT Corporation, the telecom run by Howard Jonas. Its name comes from the Hebrew for "God heals" — fitting for a company built around medicines.
CUSIP: 75062E106HealthcareUS1 holder
Total Value
$493.6K
Total Shares
150.5K
Net Share Change
+91.9K
Activity
1 buying
Investor
Value
Shares
Weight
Change
